PARP7 inhibition and a STING agonist potentiate radiation-induced immunogenicity in glioblastoma.
Overview
- Department of Radiation Oncology, Medical University of Vienna, Vienna, Austria
- Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria
- MedAustron Ion Therapy Center, Wiener Neustadt, Austria
- Max Perutz Labs, Vienna Biocenter Campus (VBC), Vienna, Austria
- Medical University of Vienna, Center for Medical Biochemistry, Vienna, Austria
- Vienna Biocenter PhD Program, A Doctoral School of the University of Vienna and the Medical University of Vienna, Vienna, Austria
- Medical University of Vienna, Center for Pathophysiology, Infectiology and Immunology, Institute for Hygiene and Applied Immunology, Vienna, Austria
- Department of Chemical Physiology and Biochemistry, Oregon Health and Science University, Portland, OR, USA
Abstract
Glioblastoma (GBM) is the most lethal form of brain cancer with an immunosuppressive tumor microenvironment (TME). Radio- and chemotherapy can modify the TME and elicit anti-tumor immunity through the STING and type I interferon (IFN-I) pathways. STING agonists or DNA damage response inhibitors can potentiate the effects of radiation by targeting the IFN-I pathway. Here, we examined the immunogenic response of GBM cells to hypofractionated or single-dose radiation combined with a STING agonist or inhibitors targeting immune signaling (PARP7), the DNA damage response, cell cycle checkpoints or autophagy. We found that hypofractionated radiation elicited a ferroptosis-dependent IFN-I response and that the PARP7 inhibitor KMR-206 and the STING agonist diABZI enhanced the effects of radiation by activating immune cells. In patient-derived GBM cancer stem cells with low STING levels, the PARP7 inhibitor was more effective at inducing immunogenic signaling compared to the STING agonist. Our results highlight the potential of PARP7 inhibitors as a new treatment to boost anti-tumor immunity in GBM, which may be more advantageous compared to STING agonists given that STING is often downregulated in GBM.
Reproduced under the paper's license (CC BY-NC), from the paper cited above.
Code
The paper links to its data and to no code of its authors: see the Data section.
Tracing map
A tracing map links a paper to the code its authors published: this paper has none, so it has no map.
Data
Datasets cited
- arrayexpress:E-MTAB-1485
8 , at ArrayExpress; found in “Data availability statement”
Data availability statement
The RNA-seq data that support the findings of this study are openly available in Array Express at https://
Reproduced under the paper's license (CC BY-NC), from the paper cited above.
Versions
The history of this record: each version stored by the harvester or made by a correction of its authors or of the maintainers of its code, and what changed in its facts. The texts of the paper (its abstract, its availability statements) are not part of it; versions that changed only those are not listed.
Version 1, 29 September 2026: the first record
Recorded: type, language, journal, volume, issue, pages, dates, 15 authors, 5 keywords, 14 MeSH terms, 1 funder, 109 references.
Cite
This paper
Lippert, L., Kleinwächter, A., Ohradanova-Repic, A., Horvat, F., Appel, L.-M., Walch, L., Bragato, N., Wimmer, J., Wopfner, H., Röhrer, A., Engl, M., Upadhyaya, K., Widder, J., Cohen, M. S., & Slade, D. (2026). PARP7 inhibition and a STING agonist potentiate radiation-induced immunogenicity in glioblastoma. Oncoimmunology, 15(1), 2656053. https://
BibTeX
@article{lippert2026parp
author = {Lippert, Luca and Kleinwächter, Ava and Ohradanova-Repic, Anna and Horvat, Filip and Appel, Lisa-Marie and Walch, Lena and Bragato, Niccolò and Wimmer, Jakob and Wopfner, Hanna and Röhrer, Anna and Engl, Magdalena and Upadhyaya, Kapil and Widder, Joachim and Cohen, Michael S and Slade, Dea},
title = {{PARP7 inhibition and a STING agonist potentiate radiation-induced immunogenicity in glioblastoma}},
journal = {Oncoimmunology},
year = {2026},
month = apr,
volume = {15},
number = {1},
pages = {2656053},
publisher = {Taylor \& Francis},
issn = {2162-4011},
doi = {10.1080/
url = {https://
pmid = {41979168},
pmcid = {PMC13081750}
}
RIS
TY - JOUR
AU - Lippert, Luca
AU - Kleinwächter, Ava
AU - Ohradanova-Repic, Anna
AU - Horvat, Filip
AU - Appel, Lisa-Marie
AU - Walch, Lena
AU - Bragato, Niccolò
AU - Wimmer, Jakob
AU - Wopfner, Hanna
AU - Röhrer, Anna
AU - Engl, Magdalena
AU - Upadhyaya, Kapil
AU - Widder, Joachim
AU - Cohen, Michael S
AU - Slade, Dea
TI - PARP7 inhibition and a STING agonist potentiate radiation-induced immunogenicity in glioblastoma
T2 - Oncoimmunology
J2 - Oncoimmunology
PY - 2026
DA - 2026/
VL - 15
IS - 1
SP - 2656053
SN - 2162-4011
PB - Taylor & Francis
DO - 10.1080/
UR - https://
LA - en
ER -
CSL-JSON
{
"id": "10.1080/
"type": "article-journal",
"title": "PARP7 inhibition and a STING agonist potentiate radiation-induced immunogenicity in glioblastoma",
"container-title": "Oncoimmunology",
"author": [
{
"family": "Lippert",
"given": "Luca"
},
{
"family": "Kleinwächter",
"given": "Ava"
},
{
"family": "Ohradanova-Repic",
"given": "Anna"
},
{
"family": "Horvat",
"given": "Filip"
},
{
"family": "Appel",
"given": "Lisa-Marie"
},
{
"family": "Walch",
"given": "Lena"
},
{
"family": "Bragato",
"given": "Niccolò"
},
{
"family": "Wimmer",
"given": "Jakob"
},
{
"family": "Wopfner",
"given": "Hanna"
},
{
"family": "Röhrer",
"given": "Anna"
},
{
"family": "Engl",
"given": "Magdalena"
},
{
"family": "Upadhyaya",
"given": "Kapil"
},
{
"family": "Widder",
"given": "Joachim"
},
{
"family": "Cohen",
"given": "Michael S"
},
{
"family": "Slade",
"given": "Dea"
}
],
"container-title-short":
"volume": "15",
"issue": "1",
"page": "2656053",
"DOI": "10.1080/
"PMID": "41979168",
"PMCID": "PMC13081750",
"ISSN": "2162-4011",
"publisher": "Taylor & Francis",
"URL": "https://
"language": "en",
"issued": {
"date-parts": [
[
2026,
4,
14
]
]
}
}
Similar papers
The papers with a page that share the most with this one: the tools found in their code, their categories, datasets, cited references and authors, the rarest counting most.
- [1] doi:10.1007/s00401-024-02688-z [code]
- Neuronal STING activation in amyotrophic lateral sclerosis and frontotemporal dementia.Journal: Acta neuropathologicaIn common: other condition, mouse, cellular / molecular, 5 references
- [2] doi:10.1038/s41467-023-36878-2 [code]
- Checkpoint kinase 1/
2 inhibition potentiates anti-tumoral immune response and sensitizes gliomas to immune checkpoint blockade. Journal: Nature communicationsIn common: other condition, mouse, cellular / molecular, 3 references - [3] doi:10.1038/s41467-023-37328-9
- STING agonist-loaded, CD47/
PD-L1-targeting nanoparticles potentiate antitumor immunity and radiotherapy for glioblastoma. Journal: Nature communicationsIn common: other condition, mouse, cellular / molecular, 3 references - [4] doi:10.1038/s42003-022-03654-9
- Combined MEK and JAK/
STAT3 pathway inhibition effectively decreases SHH medulloblastoma tumor progression. Journal: Communications biologyIn common: other condition, mouse, cellular / molecular, 6 references - [5] doi:10.1186/s13059-026-03946-x
- MER57E3 transposable elements regulate gene expression in a human cell model of neural development.Journal: Genome biologyIn common: 6 references
- [6] doi:10.7554/elife.81943
- Constitutively active STING causes neuroinflammation and degeneration of dopaminergic neurons in mice.Journal: eLifeIn common: other condition, mouse, cellular / molecular, 3 references
- [7] doi:10.1073/pnas.2111003119
- STING activation promotes robust immune response and NK cell-mediated tumor regression in glioblastoma models.Journal: Proceedings of the National Academy of Sciences of the United States of AmericaIn common: other condition, mouse, cellular / molecular, 4 references
- [8] doi:10.1242/dmm.049995
- A zebrafish model of combined saposin deficiency identifies acid sphingomyelinase as a potential therapeutic target.Journal: Disease models & mechanismsIn common: other condition, cellular / molecular, 6 references
- [9] doi:10.1038/s44319-024-00123-8
- Mcph1, mutated in primary microcephaly, is also crucial for erythropoiesis.Journal: EMBO reportsIn common: mouse, 6 references
- [10] doi:10.1016/j.molcel.2025.07.005 [code]
- Chromatin-dependent motif syntax defines differentiation trajectories.Journal: Molecular cellIn common: mouse, cellular / molecular, 5 references
Contribute
The authors of this paper can claim it, correct its record and validate its tracing map, and the maintainers of its code (its owner, or a public member of its organization) correct what it says of their repository; anyone signed in can ask for its removal. Every request goes to OSCR's own machine, which answers it; your account page follows them.
Sign in with ORCID to claim this paper as one of its authors, correct its record or validate its tracing map: when the paper's metadata lists your ORCID iD, you are recognized at once. Maintainers of its code: sign in with GitHub, then claim the repository on your account page.
Claim this paper
Correct its record
Say what each link of this record is, remove the ones that are not the paper's, add the ones that are missing. The correction becomes a new version of the record, in its Versions section.
Request its removal
To ask OSCR to remove this record, the copies of its authors' scripts or its tracing map, use the removal request page: signed in, you say who you are, what to remove and why, then review and confirm the request. Published rules decide every request (how).
Discussion, reproductions, activity
Discussion: code errors and mismatches between the code and the paper about this paper and its code, from readers and its authors, beside the paper and its tracing map.
Reproductions: reports from readers who ran the authors' code and did not get the paper's result, what they ran, with which environment, commit and data.
Activity: what happens around this paper: new versions of its record, its map's validation, discussions and reproductions. It opens with sign-in.
